Document 0074
 DOCN  M9460074
 TI    Hepatitis C, hepatitis B, and human immunodeficiency virus infections
       among non-intravenous drug-using patients attending clinics for sexually
       transmitted diseases.
 DT    9408
 AU    Thomas DL; Cannon RO; Shapiro CN; Hook EW 3rd; Alter MJ; Quinn TC;
       Division of Infectious Diseases, Johns Hopkins University School; of
       Medicine, Baltimore, MD 21205.
 SO    J Infect Dis. 1994 May;169(5):990-5. Unique Identifier : AIDSLINE
       MED/94223104
 AB    The seroprevalences of and risk factors for hepatitis C virus (HCV),
       hepatitis B virus (HBV), human immunodeficiency virus (HIV), and
       syphilis were determined among 1257 consecutive non-intravenous
       drug-using patients attending Baltimore sexually transmitted diseases
       clinics: 122 (9.7%) had antibodies to HCV (anti-HCV), 192 (15.3%) had
       antibodies to HBV (anti-HBc), 44 (3.5%) had antibodies to HIV
       (anti-HIV), and 60 (4.8%) were seropositive for syphilis. For males,
       independent predictors of anti-HCV were age > 29 years and lack of
       condom use in the month before their visit. Males with any one serologic
       marker (anti-HCV, anti-HBc, anti-HIV, or syphilis) were more likely to
       have each of the other markers. For females, anti-HCV was independently
       associated with age > 29 years and > 1 male sex partner in the prior
       month. Females with anti-HIV or anti-HBc were more likely to have
       anti-HCV. These observations among non-intravenous drug-using patients
       suggest that sexual transmission of HCV may occur.
 DE    Adolescence  Adult  Aged  Ambulatory Care Facilities
       Baltimore/EPIDEMIOLOGY  Demography  Female  Hepatitis
       B/COMPLICATIONS/*EPIDEMIOLOGY  Hepatitis
       C/COMPLICATIONS/*EPIDEMIOLOGY/TRANSMISSION  Human  HIV
       Infections/COMPLICATIONS/*EPIDEMIOLOGY  Male  Middle Age  Prevalence
       Risk Factors  Seroepidemiologic Methods  Sexually Transmitted
       Diseases/COMPLICATIONS/EPIDEMIOLOGY  Substance Abuse/*COMPLICATIONS
       Syphilis/COMPLICATIONS/EPIDEMIOLOGY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).